Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63,223,223
-
Total 13F shares
-
17,228,093
-
Share change
-
+4,107,446
-
Total reported value
-
$320,930,460
-
Price per share
-
$18.64
-
Number of holders
-
75
-
Value change
-
+$66,992,546
-
Number of buys
-
55
-
Number of sells
-
17
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q4 2021
As of 31 Dec 2021,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,228,093 shares.
The largest 10 holders included
ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, NEXT CENTURY GROWTH INVESTORS LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, JANUS HENDERSON GROUP PLC, FMR LLC, Novo Holdings A/S, and Raymond James Financial Services Advisors, Inc..
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.